-
WI HARPER GROUP
WI HARPER GROUP
target DNA in species ranging from bacteria to humans
for gene editing. Through intensive automation, Synthego
has cut the cost of synthetic guide RNA by up to 80% and
drasticall...
-
1. About – WI HARPER GROUP
the Future
We are one of the earliest VC to enter Greater China back in 1993. It was a big & bold move to venture into an unknown and untapped market where the term “venture capital” was yet to be off...
-
WI Harper Group’s 2021 Portfolio Highlights – WI HARPER GROUP
WI Harper Group | January 3, 2022 | Source: WI Harper
2021 marked a banner year for WI Harper Group. The firm saw its portfolio companies close exceeding fundraising rounds, as well as exits in variou...
-
WI Harper Group-backed RWDC Industries Raises $95M Series B2 – WI HARPER GROUP
WI Harper Group | November 24, 2021 | Source: Eco Business
RWDC Industries announced the closing of a US$95 million Series B2 funding round that will support expansion and boost production of its biod...
-
3. Our Team – Advisors – WI HARPER GROUP
Dr. Ya-Qin Zhang joined Baidu in September 2014 as President, in charge of new business.
Prior to joining Baidu, Zhang was Microsoft’s Corporate Vice President and Chairman of Asia R&D Group, leading...
-
6. Discover – WI HARPER GROUP
Source: Circle Pharma March 17, 2020 South San Francisco, CA, March 17, 2020, — Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today an...